Pure Green, a Michigan-based cannabis drug company, is seeking fresh capital to develop THC- and CBD-based products for medical use. The private placement will help the company grow Pure Green Pharmaceuticals, a research and development spin-off that is working closely with federal regulators to get ahead amid a shakeout in the marijuana industry.
"There are always investors who are looking for people who have experience doing something," Steve Goldner, CEO of Pure Green, told Cheddar. "I worked on a drug, methadone, 45 years ago. That worked out pretty well. Now we have a chance to do that with safer molecules."
For Goldner, a veteran drugmaker, scientific rigor and testing is the key to bringing the cannabis industry mainstream.
Pure Green recently met with the Food and Drug Administration (FDA), which Goldner said provided a clear pathway to the marketplace and some ideas on how to move forward. The top-down support signals a shift in how the federal agency views medical cannabis — a change of that heart stems from pressure to provide alternatives to opioid-based pain relievers.
"The FDA's idea was don't let people get into opioids and then try to get them out," he said. "Solve their pain before they have to go to opioids."
Pure Green has since focused its clinical testing on proving pain relief in users. CBD, which is found in products ranging from seltzer drinks to gummies, is key to the formula.
"CBD in some concentrations really can relieve pain," Goldner said. "FDA is right to think about that as a drug, and we've been showing them data to demonstrate how it can be used safely and effectively."
It's the job of companies like Pure Green, he added, to bring that health and safety data to the FDA and move the conversation forward around CBD and THC alike.
"They're very fair and even-handed about it," Goldner said. "They just take a little while to move."
In the meantime, research continues apace at Pure Green. The company obtained its first patent in June 2019. The patent covers a process developed by Goldner to freeze dry and extract a wide range of molecules from cannabis plant matter.
"What's important about this is that the federal government is recognizing this is serious science and serious medicine," Goldner said.
The 12-hour freeze-dry process replaces the need to dry out the plant, which can take up to two weeks and presents more risks for contamination.
"We are passionate about shifting the perception of cannabis to 'Cannabis As Medicine' and solidifying our position as a creative hub for scientists, engineers, and physicians to work legally in the cannabis space," said Goldner in a statement at the time.
Orangetheory Fitness is redefining the future of workouts with smarter tech, strength-based programming, and community-driven studios built for what’s next.
Spain's government has fined Airbnb 64 million euros or $75 million for advertising unlicensed tourist rentals. The consumer rights ministry announced the fine on Monday. The ministry stated that many listings lacked proper license numbers or included incorrect information. The move is part of Spain's ongoing efforts to regulate short-term rental companies amid a housing affordability crisis especially in popular urban areas. The ministry ordered Airbnb in May to remove around 65,000 listings for similar violations. The government's consumer rights minister emphasized the impact on families struggling with housing. Airbnb said it plans to challenge the fine in court.
Roomba maker iRobot has filed for Chapter 11 bankruptcy protection, but says that it doesn’t expect any disruptions to devices as the more than 30-year-old company is taken private under a restructuring process. iRobot said that it is being acquired by Picea through a court-supervised process. Picea is the company's primary contract manufacturer. The Bedford, Massachusetts-based anticipates completing the prepackaged chapter 11 process by February.
Serbia’s prosecutor for organized crime has charged a government minister and three others with abuse of position and falsifying of documents related to a luxury real estate project linked to U.S. President Donald Trump’s son-in-law Jared Kushner. The charges came on Monday. The investigation centers on a controversy over a a bombed-out military complex in central Belgrade that was a protected cultural heritage zone but that is facing redevelopment as a luxury compound by a company linked to Kushner. The $500 million proposal to build a high-rise hotel, offices and shops at the site has met fierce opposition from experts at home and abroad. Selakovic and others allegedly illegally lifted the protection status for the site by falsifying documentation.
